Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment - PharmaTimes Decision introduces zolbetuximab for eligible patients in NHS Scotland

#SMC #precisiononcology #precisonmedicine #gastriccancer #zolbetuximab #NHSScotland #AstellasPharma #advancedgastriccancer #gastrooesophagealjunctioncancer #adenocarcinomatumours #biomarkers #cancerbiology #phase3clinicaltrials #SPOTLIGHT #GLOW
zurl.co/7GCPi

Fezolinetant shows real-world promise for menopause symptoms - PharmaTimes Preliminary phase 4 data highlights improvements in sleep, work productivity and quality of life

#womenshealth #Fezolinetant #menopausesymptoms #phase4data #AstellasPharma #Astellas #OPTIONVMSobservationalstudy #vasomotorsymptoms #VMS #menopause #menopausalVMS #Hotflashes #nightsweats #TheMenopauseSociety #sleepoutcomes #PROMISSDSF8b #actigraphyendpoints
pharmatimes.com/news/fezolin...

HRT alternative could cause serious liver injury, manufacturer warns Serious liver injury has been observed with fezolinetant (Veoza; Astellas Pharma), a non-hormonal alternative to hormone replacement therapy (HRT), its manufacturer has warned. In a letter sent to…

A letter from #AstellasPharma has warned that serious liver injury has been observed with #fezolinetant (#Veoza), a non-hormonal alternative to #HRT